Advanced Search

Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6)

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Frequency: Quarterly

ISSN 1824-4785

Online ISSN 1827-1936

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6)

 FOREWORD THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):485-6

4th International Symposium on TArgeted Radiotherapy and Dosimetry (ISTARD): Best Ranked Abstract Publication

Chiesa C., Luster M., Lassmann M.


 SELECTED PRESENTATIONS THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):487-95

Quantification of activity by alpha-camera imaging and small-scale dosimetry within ovarian carcinoma micrometastases treated with targeted alpha therapy

Chouin N., Lindegren S., Jensen H., Albertsson P., Bäck T.


 SELECTED PRESENTATIONS THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):496-502

Personalization of radioiodine treatment for Graves’ disease: a prospective, randomized study with a novel method for calculating the optimal 131I-iodide activity based on target reduction of thyroid mass

Orsini F., Traino A. C., Grosso M., Guidoccio F., Boni G., Volterrani D., Mariani G.


 SELECTED PRESENTATIONS THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):503-8

A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres

Chiesa C., Mira M., Maccauro M., Romito R., Spreafico C., Sposito C., Bhoori S., Morosi C., Pellizzari S., Negri A., Civelli E., Lanocita R., Camerini T., Bampo C., Carrara M., Seregni E., Marchianò A., Mazzaferro V., Bombardieri E.


 SELECTED PRESENTATIONS THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):509-14

Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I

Pettinato C., Monari F., Nanni C., Allegri V., Marcatili S., Civollani S., Cima S., Spezi E., Mazzarotto R., Fanti S.


 SELECTED PRESENTATIONS THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):515-21

Dosimetry in the therapy of metastatic differentiated thyroid cancer administering high 131I activity: the experience of Busto Arsizio Hospital (Italy)

Bianchi L., Baroli A., Lomuscio G., Pedrazzini L., Pepe A., Pozzi L., Chiesa C.


 SELECTED PRESENTATIONS THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):522-8

Quantitative evaluation on [90Y] DOTATOC PET and SPECT imaging by phantom acquisitions and clinical applications in locoregional and systemic treatments

Fabbri C., Mattone V., Casi M., De Lauro F., Agostini M., Bartolini N., D’arienzo M., Marchi G., Bartolomei M., Sarti G.


 SELECTED PRESENTATIONS THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):529-37

Comparisons of dosimetric approaches for fractionated radioimmunotherapy of non-Hodgkin lymphoma

Ferrer L., Malek E., Bodet-Milin C., Legouill S., Prangère T., Robu D., Jeans S., Tipping J., Huglo D., Carpentier P., Illidge T., Kraeber-Boderé F., Morschhauser F., Bardiès M.


 SELECTED PRESENTATIONS THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):538-43

Targeted “bone-seeking” radiopharmaceuticals for palliative treatment of bone metastases: a systematic review and meta-analysis

D’angelo G., Sciuto R., Salvatori M., Sperduti I., Mantini G., Maini C. L., Mariani G.


 SELECTED PRESENTATIONS THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):544-50

Is there need for radioimmunotherapy? Results of a phase I/II study in patients with indolent B-cell lymphomas using lutetium-177-DOTA-rituximab

Forrer F., Oechslin-Oberholzer C., Campana B., Maecke H. R., Mueller-Brand J., Lohri A.


 SELECTED PRESENTATIONS THERAPY AND DOSIMETRY IN NUCLEAR MEDICINE - AN UPDATE 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):551-8

Super-selective hepatic arterial infusions as established technique (‘ARETAIEION’ Protocol) of [177Lu]DOTA-TATE in inoperable neuroendocrine liver metastases of gastro-entero-pancreatic (GEP) tumors

Limouris G. S., Karfis I., Chatzioannou A., Paphiti M. I., Lyra M., Gennatas K., Nikou G., Voros D., Pragulidis G. P., Polydorou A. A., Gouliamos A.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):559-68

The chemotherapy long-term effect on cognitive functions and brain metabolism in lymphoma patients

Baudino B., D’agata F., Caroppo P., Castellano G., Cauda S., Manfredi M., Geda E., Castelli L., Mortara P., Orsi L., Cauda F., Sacco K., Ardito R. B., Pinessi L., Geminiani G., Torta R., Bisi G.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 December;56(6):569-76

PET in the clinical work-up of patients with spondylodiscitis: a new tool for the clinician?

Skanjeti A., Penna D., Douroukas A., Cistaro A., Arena V., Leo G., Longo G., Traverso A., Belloro S., Pelosi E.


top of page